Search results

• Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson’s disease

  Author: Klisko, D. M., 2017

  Supervisor: Salvage, S. (Supervisor) & Jenner, P. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File

• Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson’s disease

  Author: Page, C., 1 Mar 2014

  Supervisor: Salvage, S. (Supervisor) & Jenner, P. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File

• Behavioural investigation into whether L-DOPA, the current 'gold standard' pharmacotherapy for Parkinson’s disease can be improved by optimising its treatment strategies

  Author: Tayarani-Binazir, K. A., 2014

  Supervisor: Salvage, S. (Supervisor) & Jenner, P. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File

• A behavioural evaluation of the potential of nNOS inhibitors to control dyskinesia in animal models of Parkinson’s disease

  Author: Hirsch, T., 1 Nov 2012

  Supervisor: Salvage, S. (Supervisor) & Jenner, P. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File

• Investigations into the Neuroprotective Effects of Osteopontin in In Vitro and In Vivo Models of Parkinsons Disease

  Author: Broom, L., 1 Sept 2012

  Supervisor: Salvage, S. (Supervisor) & Jenner, P. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File

• The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson’s disease

  Author: Ailane, S., 2012

  Supervisor: Jenner, P. (Supervisor) & Salvage, S. (Supervisor)

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File